By proceeding, you agree to our Terms of Use and Privacy Policy.
A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are utilizing the ubiquitin-proteasome, lysosome, and autophagy systems to seek out previously “undruggable” targets for therapeutic intervention. Cambridge Healthtech Institute’s two-part conference on Protein Degraders and Molecular Glues brings together experts from industry and academia to discuss targeted protein degradation as a viable therapeutic approach. Part 1 focuses on emerging assays and screening strategies for new ligases and neosubstrates for targeted degradation. The use of covalent chemistry for inducing chemical proximity and use of AI/ML predictions and modeling to enable targeted protein degradation will also be discussed.
Explore the latest advancements in targeted protein degradation.
The event focuses on emerging assays and screening strategies for new ligases and neosubstrates for targeted degradation. The use of covalent chemistry for inducing chemical proximity and use of AI/ML predictions and modeling to enable targeted protein degradation will also be discussed.
Engage in profound discussions, interact with prominent scientists, researchers, and experts who are driving advancements in this exhilarating field. This immersive experience offers you the opportunity to form valuable connections, exchange innovative ideas, and collaborate with fellow professionals who are at the forefront of research in targeted protein degradation.
Listen to experts who have made significant contributions to the field of targeted protein degradation. Gain inspiration, fresh perspectives, and innovative approaches that can drive your own research and contribute to the development of next-generation therapeutics.
Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
At Charles River, we are passionate about our role in improving the quality of people’s lives.
We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for quality and integrity.
Reaction Biology provides pre-clinical drug discovery solutions as your trusted partner.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients.
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow.
Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics.
Established in 2007, Sino Biological is a global biotechnology company manufacturing high quality research reagents for basic, translational, and clinical research.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face.
BPS manufactures one of the largest selections of recombinant enzymes, neutralizing antibodies, inhibitor assay kits, lentiviruses and cell lines for drug discovery and continues to expand its drug discovery products.
AssayQuant® mission is to support the development of more effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious conditions.
Biointron is a leading high throughput recombinant antibody/protein expression provider. From gene sequence to purified antibodies, it just takes 2 weeks.
Q² Solutions is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biospecimen and consent management solutions.
BioDuro-Sundia is a global provider of contract research, development and manufacturing outsourcing solutions.
Biosensing Instrument is a life science company that designs and supplies award winning label-free molecular interaction instruments based on the Surface Plasmon Resonance technology.
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences.
LifeSensors, Inc. is a biotechnology company leading the development of innovative research tools and services for the ubiquitin and ubiquitin-like protein pathways.
Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery.
Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.
Causaly accelerates how humans acquire knowledge and develop insights in Biomedicine.
Apex Molecular is a leading UK based Chemistry Services Contract Research Organisation based at Alderley Park, providing specialist chemistry services to the pharmaceutical, biotechnology and applied chemistry sectors.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.